Merav Baz-Hecht

Learn More
This prospective, randomized, placebo-controlled study investigated whether estrogen, tamoxifen, and raloxifene protect the skeleton from the acute catabolic effects of continuous PTH(1–34) infusion. It was infused over 24 h in 25 postmenopausal women both before and while on medication for 16–20 weeks (estrogen n = 7, raloxifene n = 5, tamoxifen n = 7,(More)
  • 1